81 FR 92021 - Sentencing Guidelines for United States Courts

UNITED STATES SENTENCING COMMISSION

Federal Register Volume 81, Issue 243 (December 19, 2016)

Page Range		92021-92022
FR Document		2016-30490

In August 2016, the Commission indicated that one of its priorities would be the ``[s]tudy of offenses involving MDMA/Ecstasy, synthetic cannabinoids (such as JWH-018 and AM-2201), and synthetic cathinones (such as Methylone, MDPV, and Mephedrone), and consideration of any amendments to the Guidelines Manual that may be appropriate in light of the information obtained from such study.'' See 81 FR 58004 (Aug. 24, 2016). As part of its statutory authority and responsibility to analyze sentencing issues, including operation of the federal sentencing guidelines, the United States Sentencing Commission is publishing this issue for comment to inform the Commission's consideration of the issues related to this policy priority. The issue for comment is set forth in the Supplementary Information portion of this notice.

Federal Register, Volume 81 Issue 243 (Monday, December 19, 2016)

[Federal Register Volume 81, Number 243 (Monday, December 19, 2016)]
[Notices]
[Pages 92021-92022]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-30490]


-----------------------------------------------------------------------

UNITED STATES SENTENCING COMMISSION


Sentencing Guidelines for United States Courts

AGENCY: United States Sentencing Commission.

ACTION: Request for public comment.

-----------------------------------------------------------------------

SUMMARY: In August 2016, the Commission indicated that one of its 
priorities would be the ``[s]tudy of offenses involving MDMA/Ecstasy, 
synthetic cannabinoids (such as JWH-018 and AM-2201), and synthetic 
cathinones (such as Methylone, MDPV, and Mephedrone), and consideration 
of any amendments to the Guidelines Manual that may be appropriate in 
light of the information obtained from such study.'' See 81 FR 58004 
(Aug. 24, 2016). As part of its statutory authority and responsibility 
to analyze sentencing issues, including operation of the federal 
sentencing guidelines, the United States Sentencing Commission is 
publishing this issue for comment to inform the Commission's 
consideration of the issues related to this policy priority. The issue 
for comment is set forth in the Supplementary Information portion of 
this notice.

DATES: Public comment regarding the issue for comment set forth in this 
notice should be received by the Commission not later than March 10, 
2017.

ADDRESSES: All written comment should be sent to the Commission by 
electronic mail or regular mail. The email address for public comment 
is [email protected]. The regular mail address for public comment 
is United States Sentencing Commission, One Columbus Circle NE., Suite 
2-500, Washington, DC 20002-8002, Attention: Public Affairs.

FOR FURTHER INFORMATION CONTACT: Christine Leonard, Director, Office of 
Legislative and Public Affairs, (202) 502-4500, [email protected].

SUPPLEMENTARY INFORMATION: The United States Sentencing Commission is 
an independent agency in the judicial branch of the United States 
Government. The Commission promulgates sentencing guidelines and policy 
statements for federal courts pursuant to 28 U.S.C. 994(a). The 
Commission also periodically reviews and revises previously promulgated 
guidelines pursuant to 28 U.S.C. 994(o) and submits guideline 
amendments to the Congress not later than the first day of May each 
year pursuant to 28 U.S.C. 994(p).
    In August 2016, the Commission indicated that one of its priorities 
would be the ``[s]tudy of offenses involving MDMA/Ecstasy, synthetic 
cannabinoids (such as JWH-018 and AM-2201), and synthetic cathinones 
(such as Methylone, MDPV, and Mephedrone), and consideration of any 
amendments to the Guidelines Manual that may be appropriate in light of 
the information obtained from such study.'' See 81 FR 58004 (Aug. 24, 
2016). The Commission intends that this study will be conducted over a 
two-year period and will solicit input, several times during this 
period, from experts and other members of the public. The Commission 
further intends that in the amendment cycle ending May 1, 2018, it may, 
if appropriate, publish a proposed amendment as a result of the study.
    MDMA, Synthetic Cathinones, and Synthetic Cannabinoids.--As part of 
the study related to this policy priority, the Commission intends to 
examine offenses involving the following controlled substances:
    Synthetic Cathinones
 MDPV (Methylenedioxypyrovalerone)
 Methylone (3,4-Methylenedioxy-N-Methylcathinone)
 Mephedrone (4-Methylmethcathinone (4-MMC))
    Synthetic Cannabinoids
 JWH-018 (1-Pentyl-1-3-1-(1-Naphthoyl)Indole)
 AM-2201 (1-(5-Fluoropenty1)-3-(1-Naphthoyl)Indole)
    MDMA/Ecstasy (3,4-Methylenedioxy-Methamphetamine)

[[Page 92022]]

    The synthetic cathinones and synthetic cannabinoids listed above 
are Schedule I controlled substances that are not currently referenced 
at Sec.  2D1.1 (Unlawful Manufacturing, Importing, Exporting, or 
Trafficking (Including Possession with Intent to Commit These 
Offenses); Attempt or Conspiracy).
    MDPV, methylone, and mephedrone, are synthetic cathinones. 
According to the National Institute on Drug Abuse, synthetic 
cathinones, also known as ``bath salts,'' are man-made substances 
related to cathinone, a stimulant found in the khat plant. See National 
Institute on Drug Abuse, DrugFacts: Synthetic Cathinones (``Bath 
Salts'') (Revised January 2016) available at https://www.drugabuse.gov/publications/drugfacts/synthetic-cathinones-bath-salts.
    JWH-018 and AM-2201 are synthetic cannabinoids, sometimes referred 
to as ``Spice'' or ``K2.'' These substances are also man-made and, in 
liquid form, can be sprayed on shredded plant material so they can be 
smoked. See National Institute of Drug Abuse, DrugFacts: Synthetic 
Cannabinoids (Revised November 2015) available at https://www.drugabuse.gov/publications/drugfacts/synthetic-cannabinoids.
    MDMA is a synthetic drug that alters the user's mood and perception 
of surrounding objects and conditions. MDMA, also known as ``ecstasy'' 
or ``molly,'' is both a stimulant and hallucinogen, and is typically 
taken in tablet or capsule form. See National Institute of Drug Abuse, 
DrugFacts: MDMA (Ecstasy/Molly) (Revised October 2016) available at 
https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly.
    Guidelines Penalty Structure.--When a drug trafficking offense 
involves a controlled substance not specifically referenced in the 
guidelines, the Commentary to Sec.  2D1.1 instructs the court to 
``determine the base offense level using the marihuana equivalency of 
the most closely related controlled substance referenced in [Sec.  
2D1.1].'' See USSG Sec.  2D1.1, comment. (n.6). The guidelines 
establish a three-step process for making this determination. See USSG 
Sec.  2D1.1, comment. (n.6, 8).
    First, courts must determine the most closely related controlled 
substance by considering the following factors to the extent 
practicable:
    (A) Whether the controlled substance not referenced in Sec.  2D1.1 
has a chemical structure that is substantially similar to a controlled 
substance referenced in this guideline.
    (B) Whether the controlled substance not referenced in Sec.  2D1.1 
has a stimulant, depressant, or hallucinogenic effect on the central 
nervous system that is substantially similar to the stimulant, 
depressant, or hallucinogenic effect on the central nervous system of a 
controlled substance referenced in this guideline.
    (C) Whether a lesser or greater quantity of the controlled 
substance not referenced in Sec.  2D1.1 is needed to produce a 
substantially similar effect on the central nervous system as a 
controlled substance referenced in this guideline.
    Once the most closely related controlled substance is determined, 
the next step is to refer to the marihuana equivalency from the Drug 
Equivalency Tables at Application Note 8(D) for the most closely 
related controlled substance to convert the quantity of controlled 
substance in the offense into its equivalent quantity of marihuana. The 
final step is to find the equivalent quantity of marihuana in the Drug 
Quantity Table at Sec.  2D1.1(c) and use the corresponding offense 
level as the base offense level of the controlled substance involved in 
the offense.
    For example, in cases involving methylone, Commission data 
indicates that in fiscal year 2015, the courts always identified MDMA 
as its most closely related controlled substance. The marihuana 
equivalency of MDMA is 1 gm MDMA = 500 gm marihuana. Pursuant to the 
Drug Equivalency Tables, when sentencing methylone offenders, this is 
the equivalency to be used. Thus, if an offender is accountable for 50 
grams of methylone, the base offense level at Sec.  2D1.1 would be 
determined by multiplying the 50 grams by 500 grams of marihuana. The 
resulting equivalency of 25,000 grams of marihuana provides for a base 
offense level 16.
    In recent years, the Commission has received comment from the 
public suggesting that questions regarding ``the most closely related 
controlled substance'' require courts to hold extensive hearings. In 
addition, the Commission has heard that courts have identified 
different controlled substances as the ``most closely related 
controlled substance'' to the synthetic cathinones and synthetic 
cannabinoids included in the Commission's study and, in some cases, 
adjusted the marihuana equivalency to account for perceived differences 
between the ``most closely related controlled substance'' and the 
controlled substance involved in the offense. Both outcomes may result 
in sentencing disparities among similarly situated defendants. To 
possibly alleviate these issues, one possible outcome of the 
Commission's study may be to establish marihuana equivalencies for each 
of the synthetic cathinones (MDPV, methylone, and mephedrone) and 
synthetic cannabinoids (JWH-018 and AM-2201). The Commission decided to 
include MDMA in its study because courts have identified MDMA as the 
most closely related controlled substance referenced in Sec.  2D1.1 to 
methylone.
    Issue for Comment.--In determining the marihuana equivalencies for 
specific controlled substances, the Commission has considered, among 
other things, the chemical structure, the pharmacological effects, the 
legislative and scheduling history, potential for addiction and abuse, 
the pattern of abuse and harms associated with abuse, and the patterns 
of trafficking and harms associated with trafficking.
    The Commission invites general comment on any or all of these 
factors as they relate to the Commission's study of synthetic 
cathinones (MDPV, methylone, and mephedrone) and synthetic cannabinoids 
(JWH-018 and AM-2201).
    The Commission further seeks broad comment on offenses involving 
synthetic cathinones (MDPV, methylone, and mephedrone) and synthetic 
cannabinoids (JWH-018 and AM-2201), and the offenders involved in such 
offenses. What is the conduct involved in such offenses and the nature 
and seriousness of the harms posed by such offenses? How these offenses 
and offenders compare with other drug offenses and drug offenders? How 
are these substances manufactured, distributed, possessed, and used? 
What are the characteristics of the offenders involved in these various 
activities? What harms are posed by these activities?
    Which of the controlled substances currently referenced in Sec.  
2D1.1 should be identified as the ``most closely related controlled 
substance'' to any of the synthetic cathinones and synthetic 
cannabinoids included in the Commission's study? To what extent does 
the synthetic cathinone or synthetic cannabinoid differ from its ``most 
closely related controlled substance''?

    Authority: 28 U.S.C. 994(a), (o), (p), (x); USSC Rules of 
Practice and Procedure 4.4.

Patti B. Saris,
Chair.
[FR Doc. 2016-30490 Filed 12-16-16; 8:45 am]
 BILLING CODE 2210-40-P

Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Notices 92021

Note 2(A)(i) by striking ‘‘as determined The Commentary to § 2Q1.1 captioned ADDRESSES: All written comment should
under the provisions of § 1B1.2 ‘‘Statutory Provisions’’ is amended by be sent to the Commission by electronic
(Applicable Guidelines) for the offense striking ‘‘42 U.S.C. 6928(e)’’ and mail or regular mail. The email address
of conviction’’ and inserting the inserting ‘‘42 U.S.C. 6928(e), for public comment is Public_
following: ‘‘specifically referenced in 7413(c)(5)’’, and by inserting at the end Comment@ussc.gov. The regular mail
Appendix A (Statutory Index) for the the following: ‘‘For additional statutory address for public comment is United
offense of conviction, as determined provision(s), see Appendix A (Statutory States Sentencing Commission, One
under the provisions of § 1B1.2 Index).’’. Columbus Circle NE., Suite 2–500,
(Applicable Guidelines)’’. The Commentary to § 2Q1.2 captioned Washington, DC 20002–8002, Attention:
‘‘Statutory Provisions’’ is amended by Public Affairs.
(B) Title References to § 4A1.3 striking ‘‘7413’’ and inserting FOR FURTHER INFORMATION CONTACT:
The Commentary to § 2Q1.3 captioned ‘‘7413(c)(1)–(4)’’. Christine Leonard, Director, Office of
‘‘Application Notes’’ is amended in The Commentary to § 2Q1.3 captioned Legislative and Public Affairs, (202)
Note 8 by striking ‘‘Adequacy of ‘‘Statutory Provisions’’ is amended by 502–4500, pubaffairs@ussc.gov.
Criminal History Category’’ and striking ‘‘7413’’ and inserting SUPPLEMENTARY INFORMATION: The
inserting ‘‘Departures Based on ‘‘7413(c)(1)–(4)’’. United States Sentencing Commission is
Inadequacy of Criminal History Section 5D1.3(a)(4) is amended by an independent agency in the judicial
Category (Policy Statement)’’. striking ‘‘release on probation’’ and branch of the United States
The Commentary to § 2R1.1 captioned inserting ‘‘release on supervised Government. The Commission
‘‘Application Notes’’ is amended in release’’. promulgates sentencing guidelines and
Note 7 by striking ‘‘Adequacy of Appendix A (Statutory Index) is policy statements for federal courts
Criminal History Category’’ and amended in the line referenced to 18 pursuant to 28 U.S.C. 994(a). The
inserting ‘‘Departures Based on U.S.C. 371 by rearranging the guidelines Commission also periodically reviews
Inadequacy of Criminal History to place them in proper order, and in and revises previously promulgated
Category (Policy Statement)’’. the line referencing 18 U.S.C. 1591 by guidelines pursuant to 28 U.S.C. 994(o)
Section 4A1.2 is amended in rearranging the guidelines to place them and submits guideline amendments to
subsections (h) through (j) by striking in proper order. the Congress not later than the first day
‘‘Adequacy of Criminal History [FR Doc. 2016–30493 Filed 12–16–16; 8:45 am] of May each year pursuant to 28 U.S.C.
Category’’ each place such term appears BILLING CODE 2210–40–P 994(p).
and inserting ‘‘Departures Based on In August 2016, the Commission
Inadequacy of Criminal History indicated that one of its priorities would
Category (Policy Statement)’’. UNITED STATES SENTENCING be the ‘‘[s]tudy of offenses involving
The Commentary to § 4A1.2 captioned COMMISSION MDMA/Ecstasy, synthetic cannabinoids
‘‘Application Notes’’ is amended in (such as JWH–018 and AM–2201), and
Notes 6 and 8 by striking ‘‘Adequacy of Sentencing Guidelines for United synthetic cathinones (such as
Criminal History Category’’ both places States Courts Methylone, MDPV, and Mephedrone),
such term appears and inserting and consideration of any amendments
‘‘Departures Based on Inadequacy of AGENCY: United States Sentencing
Commission. to the Guidelines Manual that may be
Criminal History Category (Policy appropriate in light of the information
Statement)’’. ACTION: Request for public comment.
obtained from such study.’’ See 81 FR
The Commentary to § 4B1.4 captioned 58004 (Aug. 24, 2016). The Commission
SUMMARY: In August 2016, the
‘‘Background’’ is amended by striking intends that this study will be
Commission indicated that one of its
‘‘Adequacy of Criminal History conducted over a two-year period and
priorities would be the ‘‘[s]tudy of
Category’’ and inserting ‘‘Departures will solicit input, several times during
offenses involving MDMA/Ecstasy,
Based on Inadequacy of Criminal this period, from experts and other
synthetic cannabinoids (such as JWH–
History Category (Policy Statement)’’. members of the public. The Commission
018 and AM–2201), and synthetic
(C) Clerical Changes cathinones (such as Methylone, MDPV, further intends that in the amendment
and Mephedrone), and consideration of cycle ending May 1, 2018, it may, if
The Commentary to § 1B1.13
any amendments to the Guidelines appropriate, publish a proposed
captioned ‘‘Application Notes’’ is
Manual that may be appropriate in light amendment as a result of the study.
amended in Note 4 by striking ‘‘factors
of the information obtained from such MDMA, Synthetic Cathinones, and
set forth 18 U.S.C. 3553(a)’’ and
study.’’ See 81 FR 58004 (Aug. 24, Synthetic Cannabinoids.—As part of the
inserting ‘‘factors set forth in 18 U.S.C.
2016). As part of its statutory authority study related to this policy priority, the
3553(a)’’.
and responsibility to analyze sentencing Commission intends to examine
Section 2D1.11 is amended in
issues, including operation of the offenses involving the following
subsection (d)(6) by striking
federal sentencing guidelines, the controlled substances:
‘‘Pseuodoephedrine’’ and inserting Synthetic Cathinones
‘‘Pseudoephedrine’’; United States Sentencing Commission is
publishing this issue for comment to • MDPV (Methylenedioxypyrovalerone)
and in subsection (e)(2), under the • Methylone (3,4-Methylenedioxy-N-
heading relating to List I Chemicals, by inform the Commission’s consideration
Methylcathinone)
striking the period at the end and of the issues related to this policy
• Mephedrone (4-Methylmethcathinone
priority. The issue for comment is set
sradovich on DSK3GMQ082PROD with NOTICES

inserting a semicolon. (4–MMC))
The Commentary to § 2M2.1 forth in the Supplementary Information Synthetic Cannabinoids
captioned ‘‘Statutory Provisions’’ is portion of this notice. • JWH-018 (1-Pentyl-1-3-1-(1-
amended by striking ‘‘§ 2153’’ and DATES: Public comment regarding the Naphthoyl)Indole)
inserting ‘‘§§ 2153’’, and by inserting at issue for comment set forth in this • AM-2201 (1-(5-Fluoropenty1)-3-(1-
the end the following: ‘‘For additional notice should be received by the Naphthoyl)Indole)
statutory provision(s), see Appendix A Commission not later than March 10, MDMA/Ecstasy (3,4-Methylenedioxy-
(Statutory Index).’’. 2017. Methamphetamine)

VerDate Sep<11>2014 20:55 Dec 16, 2016 Jkt 241001 PO 00000 Frm 00122 Fmt 4703 Sfmt 4703 E:\FR\FM\19DEN1.SGM 19DEN1

92022 Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Notices

The synthetic cathinones and effect on the central nervous system that equivalencies for each of the synthetic
synthetic cannabinoids listed above are is substantially similar to the stimulant, cathinones (MDPV, methylone, and
Schedule I controlled substances that depressant, or hallucinogenic effect on mephedrone) and synthetic
are not currently referenced at § 2D1.1 the central nervous system of a cannabinoids (JWH-018 and AM-2201).
(Unlawful Manufacturing, Importing, controlled substance referenced in this The Commission decided to include
Exporting, or Trafficking (Including guideline. MDMA in its study because courts have
Possession with Intent to Commit These (C) Whether a lesser or greater identified MDMA as the most closely
Offenses); Attempt or Conspiracy). quantity of the controlled substance not related controlled substance referenced
MDPV, methylone, and mephedrone, referenced in § 2D1.1 is needed to
in § 2D1.1 to methylone.
are synthetic cathinones. According to produce a substantially similar effect on
the National Institute on Drug Abuse, the central nervous system as a Issue for Comment.—In determining
synthetic cathinones, also known as controlled substance referenced in this the marihuana equivalencies for specific
‘‘bath salts,’’ are man-made substances guideline. controlled substances, the Commission
related to cathinone, a stimulant found Once the most closely related has considered, among other things, the
in the khat plant. See National Institute controlled substance is determined, the chemical structure, the pharmacological
on Drug Abuse, DrugFacts: Synthetic next step is to refer to the marihuana effects, the legislative and scheduling
Cathinones (‘‘Bath Salts’’) (Revised equivalency from the Drug Equivalency history, potential for addiction and
January 2016) available at https:// Tables at Application Note 8(D) for the abuse, the pattern of abuse and harms
www.drugabuse.gov/publications/ most closely related controlled associated with abuse, and the patterns
drugfacts/synthetic-cathinones-bath- substance to convert the quantity of of trafficking and harms associated with
salts. controlled substance in the offense into trafficking.
JWH-018 and AM-2201 are synthetic its equivalent quantity of marihuana.
cannabinoids, sometimes referred to as The final step is to find the equivalent The Commission invites general
‘‘Spice’’ or ‘‘K2.’’ These substances are quantity of marihuana in the Drug comment on any or all of these factors
also man-made and, in liquid form, can Quantity Table at § 2D1.1(c) and use the as they relate to the Commission’s study
be sprayed on shredded plant material corresponding offense level as the base of synthetic cathinones (MDPV,
so they can be smoked. See National offense level of the controlled substance methylone, and mephedrone) and
Institute of Drug Abuse, DrugFacts: involved in the offense. synthetic cannabinoids (JWH-018 and
Synthetic Cannabinoids (Revised For example, in cases involving AM-2201).
November 2015) available at https:// methylone, Commission data indicates The Commission further seeks broad
www.drugabuse.gov/publications/ that in fiscal year 2015, the courts
comment on offenses involving
drugfacts/synthetic-cannabinoids. always identified MDMA as its most
synthetic cathinones (MDPV,
MDMA is a synthetic drug that alters closely related controlled substance.
The marihuana equivalency of MDMA methylone, and mephedrone) and
the user’s mood and perception of
surrounding objects and conditions. is 1 gm MDMA = 500 gm marihuana. synthetic cannabinoids (JWH-018 and
MDMA, also known as ‘‘ecstasy’’ or Pursuant to the Drug Equivalency AM-2201), and the offenders involved
‘‘molly,’’ is both a stimulant and Tables, when sentencing methylone in such offenses. What is the conduct
hallucinogen, and is typically taken in offenders, this is the equivalency to be involved in such offenses and the nature
tablet or capsule form. See National used. Thus, if an offender is accountable and seriousness of the harms posed by
Institute of Drug Abuse, DrugFacts: for 50 grams of methylone, the base such offenses? How these offenses and
MDMA (Ecstasy/Molly) (Revised offense level at § 2D1.1 would be offenders compare with other drug
October 2016) available at https:// determined by multiplying the 50 grams offenses and drug offenders? How are
www.drugabuse.gov/publications/ by 500 grams of marihuana. The these substances manufactured,
drugfacts/mdma-ecstasymolly. resulting equivalency of 25,000 grams of distributed, possessed, and used? What
Guidelines Penalty Structure.—When marihuana provides for a base offense are the characteristics of the offenders
a drug trafficking offense involves a level 16. involved in these various activities?
controlled substance not specifically In recent years, the Commission has What harms are posed by these
referenced in the guidelines, the received comment from the public activities?
Commentary to § 2D1.1 instructs the suggesting that questions regarding ‘‘the
most closely related controlled Which of the controlled substances
court to ‘‘determine the base offense
substance’’ require courts to hold currently referenced in § 2D1.1 should
level using the marihuana equivalency
of the most closely related controlled extensive hearings. In addition, the be identified as the ‘‘most closely
substance referenced in [§ 2D1.1].’’ See Commission has heard that courts have related controlled substance’’ to any of
USSG § 2D1.1, comment. (n.6). The identified different controlled the synthetic cathinones and synthetic
guidelines establish a three-step process substances as the ‘‘most closely related cannabinoids included in the
for making this determination. See controlled substance’’ to the synthetic Commission’s study? To what extent
USSG § 2D1.1, comment. (n.6, 8). cathinones and synthetic cannabinoids does the synthetic cathinone or
First, courts must determine the most included in the Commission’s study synthetic cannabinoid differ from its
closely related controlled substance by and, in some cases, adjusted the ‘‘most closely related controlled
considering the following factors to the marihuana equivalency to account for substance’’?
extent practicable: perceived differences between the
Authority: 28 U.S.C. 994(a), (o), (p), (x);
‘‘most closely related controlled
sradovich on DSK3GMQ082PROD with NOTICES

(A) Whether the controlled substance USSC Rules of Practice and Procedure 4.4.
not referenced in § 2D1.1 has a chemical substance’’ and the controlled substance
structure that is substantially similar to involved in the offense. Both outcomes Patti B. Saris,
a controlled substance referenced in this may result in sentencing disparities Chair.
guideline. among similarly situated defendants. To [FR Doc. 2016–30490 Filed 12–16–16; 8:45 am]
(B) Whether the controlled substance possibly alleviate these issues, one
BILLING CODE 2210–40–P
not referenced in § 2D1.1 has a possible outcome of the Commission’s
stimulant, depressant, or hallucinogenic study may be to establish marihuana

VerDate Sep<11>2014 20:55 Dec 16, 2016 Jkt 241001 PO 00000 Frm 00123 Fmt 4703 Sfmt 9990 E:\FR\FM\19DEN1.SGM 19DEN1

Document Created: 2016-12-17 03:15:14
Document Modified: 2016-12-17 03:15:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Request for public comment.
Dates		Public comment regarding the issue for comment set forth in this notice should be received by the Commission not later than March 10, 2017.
Contact		Christine Leonard, Director, Office of Legislative and Public Affairs, (202) 502-4500, [email protected]
FR Citation		81 FR 92021